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In this work, the novel bifunctional nanosized ionic liquid catalyst [4,4'-bipyridine]-1,1'-diium trinitromethanide (BPDTNM) 
was designed synthesized and characterized by using FT-IR, 
1
H and 
13
C NMR, X-ray diffraction patterns (XRD), scanning 
electron microscopy (SEM), high resolution transmission electron microscopy (HRTEM), thermogravimetry (TG), derivative 
thermogravimetry (DTG) analysis, differential thermal analysis (DTA), and HPLC-mass spectroscopy. The synthesized 
nanosized catalyst was successfully applied to the synthesis of 1-(benzoimidazolylamino)methyl-2-naphthol derivatives via 
a straightforward one-pot three component condensation reaction of 2-aminobenzimidazole, 2-naphthol, and a wide 
range of aromatic aldehydes under mild and solvent-free conditions. 
Introduction 
Benzimidazole derivatives are interesting heterocyclic compounds 
which are present in a wide variety of biologically active natural 
products [1-3]. Some important benzimidazole-derivatives such as, 
omeprazole, timoprazole, DMA, telmisartan, rabeprazole, and 
thiabendazole [4,5] have been recently shown as important and 
renowned marketed drugs with antibacterial and anthelminthic 
activities, among others. Furthermore, benzimidazole derivatives 
can interact with DNA, which converts them in versatile drugs 
targeting DNA and DNA associated processes [6]. Other interesting 
applications of benzimidazoles include their used as ionic liquids [7] 
and N-heterocyclic carbine precursors [8,9].  
Guanidine-containing organic compounds such as 2-
aminobenzimidazole [10,11] present a wide spectrum of 
applications in the field of pharmaceutical and biological drug 
design, being the activity against multidrug resistant bacteria the 
most notable example (Scheme 1) [12-15]. More recently, chiral 2-
aminobenzimidazoles have been successfully used as bifunctional 
Brønsted base/hydrogen bonding organocatalysts [16-20].  
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Scheme 1: Some therapeutic agents containing 2-
aminobenzimidazole moiety 
In the last two decades, ionic liquids have played crucial roles in 
different fields of science emerging as an interdisciplinary area to 
tackle controversial scientific issues [7,21,22]. Moreover, due to the 
compliance with green chemistry fundamentals [23] as well as the 
versatility of ionic liquids as solvents, catalysts, and reagents for 
different synthetic and industrial applications, the synthesis, 
chemistry and capabilities of these materials have been well 
investigated and reported in the literature [24-29]. Despite the 
advantages of ionic liquid systems in the development of green and 
sustainable methodologies, many of these materials have been 
recently found to be toxic towards cells and living organisms 
[30,31]. Therefore, the synthesis of new and green task-specific 
molten salts with nanosized morphology could address the above 
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mentioned demerits and open a new vista towards ionic liquids 
future. 
Due to the widespread benefits of one-pot multicomponent 
processes in the fields of drug discovery, natural product 
production, library generation, diversity-oriented synthesis (DOS), 
and combinatorial chemistry, this versatile synthetic tool has 
persuaded both methodological and synthetic chemists to use it for 
the preparation of biological pharmacophores under eco-friendly 
conditions [32-37]. 
In the present paper, following of our continuous studies on the 
knowledge-based improvement of magnetically supported ionic 
liquids and nanosized molten salts as efficient catalysts for the 
construction of pharmaceutical active molecules [38-46], we 
present the design and preparation of [4,4'-bipyridine]-1,1'-diium 
trinitromethanide (BPDTNM, 5) as a nanosized ionic liquid catalyst  
able to promote the synthesis of 1-(benzoimidazolylamino)methyl-
2-naphthol derivatives in a green and simple environmentally gentle 
manner (Schemes 2 and 3).  
 
 
Scheme 2: Construction of nanosized ionic liquid catalyst 5 
 
Scheme 3: Synthesis of target molecules 6a-o promoted by 
nanocatalyst 5 
Result and discussion 
The general method for the synthesis of the nanosize ionic liquid 
catalyst 5 is shown in scheme 2, adapted from our previous studies 
[45,46]. In the present method, to an acetonitrile solution of 4,4'-
bipyridine, 2 equivalents of trinitromethane were added. The [4,4'-
bipyridine]-1,1'-diium trinitromethanide (BPDTNM) 5 particles thus 
obtained were easily isolated and purified by filtration and 
subsequent washings with MeCN. 
To ensure construction of the novel nano ionic liquid 5 as a 
bifunctional catalyst, this material was analyzed using different  
techniques such as,  FT-IR, 
1
H and 
13
C NMR, X-ray diffraction 
patterns (XRD), scanning electron microscopy (SEM), high resolution 
transmission electron microscopy (HRTEM), thermogravimetry (TG), 
derivative thermogravimetry (DTG), differential thermal analysis 
(DTA), and HPLC-mass spectrometry. All the investigated technical 
skills were synergistic and verified the synthesis of BPDTNM.  
The FT-IR spectrum of the prepared nano ionic liquid catalyst 5 was 
investigated and compared with the starting materials 
trinitromethane and 4,4'-bipyridine (Figure 1). The broad peak at 
3451 cm
-1
 can be used as a proof for distinguishing the -NH 
stretching vibration mode within the structure. On the other hand, 
the absorption band at 2934 cm
-1
, corresponding to the stretching 
vibration of the aliphatic C-H bond in trinitromethanide (Figure 1a), 
is completely absent in the spectrum of 5 (Figure1c). As illustrated 
in the FT-IR spectra (Figures 1a and 1b), all the characteristic 
absorption bands of the different functional groups [ʋ
 
C=C (1595 
cm
-1
), ʋ
 
=C-H (3034 cm
-1
), and ʋas/ʋs NO2 (1625, 1468 cm
-1
)] can be 
identified in Figure 1c generally showing redshifts in catalyst 5. 
 
Figure 1: FT-IR spectrum of a) trinitromethane, b) 4,4'-bipyridine, 
and c) catalyst 5.  
As portrayed in Figure 2, the 
1
H- and 
13
CNMR spectra (DMSO-d6) of 
5, verified the formation of the catalyst. In the 
1
H NMR spectrum, 
the aromatic protons of the 4,4'-bipyridine rings, resonate as two 
multiplets in the aromatic region. The existence of –NH pyridinium 
groups within the structure of the nanosized catalyst was confirmed 
by observation of corresponding broad singlet at 12.5 ppm (Figure 
2a). With respect to the 
13
CNMR spectrum, the resonance peak at 
160.9 ppm is ascribed to the trinitromethanide carbon, while 
aromatic carbon atoms appear at 125.8, 122.6, and 119.4 ppm 
(Figure 2b). 
An insight into catalyst 5 was also performed using crystal structure 
determination by X-ray diffraction (XRD) analysis (Figure 3). From 
this study, it can be deduced that 5 has a crystalline nature 
appearing the related diffraction lines at 2θ = 19.80
 o
, 20.60
 o
, 24.70
 
o
, 26.30
 o
, 28.30
o
, 29.40
o
, and 31.20
o
. Furthermore, the average 
crystalline size D (nm) of 5 could be estimated according to the 
N
N
NO2O2N
NO2
MeCN, r.t., 3h
2 eq.
HN NH
5
NO2
O2N
O2N
NO2
O2N
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Figure 2: 
1
HNMR (a) and 
13
CNMR (b) spectrum of [4,4'-bipyridine]-
1,1'-diium trinitromethanide (BPDTNM) 5 
Scherrer equation D = Kλ/(β cosθ), where λ is the X-ray 
wavelength of Cu kα (1.54Å), K is the Scherrer constant with a 
value of 0.9, β is the peak width at half maximum (FWHM) of the 
peak in radians, and θ is the Bragg diffraction angle. The XRD 
information, including the 2θ value, peak width, particle size, 
and interplanar distance, is reported in Table 1. According to the 
Scherrer formula, catalyst 5 particle size is estimated to be 
between 15 and 33 nm. 
 
Figure 3: XRD pattern of catalyst 
Table 1: XRD data for 5. 
Entry 2θ 
Peak width [FWHM] 
(degree) 
Size 
[nm] 
Interplanar 
distance [nm] 
1 19.80 0.32 25.21 0.447859 
2 20.60 0.24 33.65 0.430643 
3 24.70 0.48 16.95 0.360011 
4 26.30 0.30 27.20 0.338460 
5 28.30 0.55 14.90 0.314978 
6 29.40 0.45 18.25 0.303439 
7 31.20 0.53 15.53 0.295580 
Scanning electron microscopy (SEM) and high-resolution 
transmission electron microscopy (HRTEM) are two helpful 
techniques which provide valuable information about particle size 
and morphology of materials. Figure 4 shows the SEM and HRTEM 
images of catalyst 5 crystals, where lattice fringes with three 
different inter-planar distances of 0.43, 0.33, and 0.30 nm 
corresponding to contrast profiles of the 2θ = 20.60, 26.30, 29.40 
degree diffraction lines are clearly revealed (Figure 4a-c). Also, 
according to the obtained SEM and HRTEM micrographs, the nano-
catalyst particle size was determined to be between 33.6 and 60.1 
nm, which is in accordance with the extracted information from the 
XRD analysis.  
 
 
Figure 4: SEM (a-b) and HRTEM (c-e) micrographs of 5  
In order to monitor the thermal stability and behavior of the [4,4'-
bipyridine]-1,1'-diium trinitromethanide (BPDTNM), the 
thermogravimetric analysis (TGA), differential thermal analysis 
(a) (b) 
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(DTA), and differential thermogravimetry (DTG) were conducted 
(Figure 5). As depicted, the main weight loss and decomposition of 
the target catalyst took place around 200-250 
o
C in a single 
exothermic step, indicating a good thermal stability (up to 200 
o
C) 
of 5 which and enabling its use at elevated temperatures.  
 
Figure 5: Thermal stability studies of 5: (a) thermogravimetric 
analysis and differential thermogravimetry (TGA/DTG). (b) 
thermogravimetric analysis and differential thermal analysis 
(TGA/DTA). 
Catalyst 5 was also analyzed by HPLC−electrospray mass 
spectrometry. As depicted in Figure 6a for the positive mode, under 
the analysis conditions, we only detected a peak at m/z = 157, 
corresponding to the [4,4'-bipyridin]-1-ium moiety. When analyzing 
the negative mass spectrum (Figure 6b), and due to the aqueous 
instability of the trinitromethanide carbanion, different identified 
[(226: −C(OH)(NO2)2CH(NO2)2; 209: 
−C(NO2)2CH(NO2)2] and non-
identified polynitro coupled species were detected [47]. 
 
 
Figure 6: a) Low-resolution positive mode HPLC−electrospray mass 
spectrum of catalyst 5. b) Low-resolution negative mode 
HPLC−electrospray mass spectrum of catalyst 5.  
After the structural analysis of the prepared nano ionic liquid 5, we 
proved its catalytic activity in the synthesis of 1-
(benzoimidazolylamino)methyl-2-naphthol derivatives via a one-pot 
condensation reaction between aromatic aldehydes, 2-
aminobenzimidazole and 2-naphthol. Initially, to evaluate the effect 
on the yield of the different reaction conditions involved in the 
process, we studied the condensation reaction of 4-
chlorobenzaldehyde, 2-aminobenzimidazole, and 2-naphthol 
(Scheme 4). After a careful screening of temperatures, catalyst 
loadings, and solvents (Table 2), the optimized reaction conditions 
for the synthesis of 1-(((1H-benzo[d]imidazol-2-yl)amino)(4-
chlorophenyl)methyl)naphthalen-2-ol (6a) involved the use of 1 
mol% of 5 at 80 
o
C under neat conditions (Table 2, entry 1).  
OH
NH
NHN
O
H
NH
N
H2N
5, 1 mol %
Solvent free, 80 oC
25 min, 90%
OH
Cl
Cl
6a  
Scheme 4: Model reaction for the evaluation of the reaction 
conditions. 
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Table 2: Optimization of reaction conditions for the synthesis of molecule 6a.1 
Entry Solvent Catalyst loading (mol%) Temperature (oC) Time (min) Yield (%)2 
1 - 1 80 25 90 
2 - 1 60 40 80 
3 - 1 100 20 90 
4 - - 80 60 40 
5 - 0.5 80 35 78 
6 - 1.5 80 25 91 
7 Water 1 80 60 15 
8 Ethanol 1 reflux 60 - 
9 Acetonitrile 1 reflux 70 - 
10 Ethyl acetate 1 reflux 70 - 
11 n-Hexane 1 reflux 50 20 
1 Reaction conditions: 4-chlorobenzaldehyde (1 mmol, 0.140 g), 2-aminobenzimidazole (1 mmol, 0.133 g), 2-naphthol (1 
mmol, 0.144 g). 
2 
Isolated yield. 
Also, at the optimal reaction conditions for the model test (1 
mol% of catalyst, 80 
o
C under solvent free conditions, Scheme 4) 
in a comparative mode, the catalytic performance of the novel 
nanosized ionic liquid catalyst 5 and three ionic liquids with 
trinitromethan anion including {[1,4-DHPyrazine][C(NO2)3]2}, 
{[HMIM] C(NO2)3} and {[2,6-DMPyH]C(NO2)3} were investigated. 
The achieved data indicated that the novel ionic liquid 5 
performs better than other catalysts and gives better 
experimental results (Table 3).   
To demonstrate the scope and efficiency of the optimized 
nanocatalyzed construction of 1-functionalized 2-naphthols 6, a 
wide series of aromatic aldehydes, including electron-donating 
and electron-withdrawing substituents, were submitted to the 
one-pot reaction with 2-aminobenzimidazole and 2-naphthol. As 
depicted in Table 4, irrespective of the electronic nature of the 
aromatic aldehyde, all the tested reactions afforded the target 
compounds in short times with high to excellent yields. 
Interestingly, this methodology could be also applied to 
terephthalaldehyde, electrophile which afforded the sterically 
crowded compound 6n in a 90% yield after 30 min (Table 4, 
entry 14). 
Table 3: Screening of the catalysts with trinitromethan anion for 
the synthesis of compound 6a 
Ref. Yield 
(%) 
Time 
(min.) 
Applied catalyst  Entry 
46a 85 30 {[1,4-DHPyrazine][C(NO2)3]2}   1 
46b 80 40 {[HMIM]C(NO2)3}  2 
46c 83 30 {[2,6-DMPyH]C(NO2)3}  3 
 - 90 25 Novel ionic liquid catalyst 5  4 
 
Table 4: 5-catalyzed synthesis of products 6a-o under solvent free conditions at 80 
o
C.
1 
Entry R
 Time 
(min) 
Structure Product Yield (%)
2
 M.p. (
o
C)
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1 4-Cl 25 
 
6a 90 195-197
 
2 4-MeO 28 
 
6b 90 
171-173 
 
3 H 25 
 
6c 89 
195-196 
 
4 4-Br 20 
 
6d 90 
199-201 
 
5 2,6-F2 20 
 
6e 89 152-154
 
6 3,5-F2 20 
 
6f 92 207-209
 
7 4-F 25 
 
6g 88 195-196
 
8 4-Me 30 
OH
NH
NH
N
Me
 
6h 87 182-184 
9 3-OH-4-Me 30 
 
6i 85 166-168
 
Page 6 of 12New Journal of Che istry
N
ew
Jo
ur
na
lo
fC
he
m
is
tr
y
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
24
 A
pr
il 
20
17
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
id
ad
 d
e 
A
lic
an
te
 o
n 
25
/0
4/
20
17
 0
8:
30
:0
4.
 
View Article Online
DOI: 10.1039/C6NJ04074H
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 7  
Please do not adjust margins 
Please do not adjust margins 
10 3-EtO-4-OH 35 
 
6j 80 182-184
 
11 3-NO2 25 
 
6k 90 197-198
 
12 2-Cl 24 
 
6l 89 144-146
 
13 3,4-(MeO)2 36 
 
6m 83 187-190
 
14 Terephthalaldehyde 30 
 
6n 90 206-208 
15 1-naphthaldehyde 30 
 
6o 85 149-151 
1Reaction conditions: arylaldehydes (1 mmol), 2-aminobenzimidazole (1 mmol, 0.133 g), 2-naphthol (1 mmol, 0.144 g). 
2
Isolated yield. 
A plausible mechanistic route of the 5-catalyzed synthesis of 
compounds 6 is presented in Scheme 5. We suggest that in the 
presence of catalyst 5, the activated aryl aldehydes undergo 
nucleophilic attack from 2-naphtol to generate the related 
Knoevenagel adduct A. Then, this activated electrophile suffers 
Michael addition from 2-aminobenzimidazole to afford 
intermediate B, which after a proton transfer process generates 
the final product 6. 
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Scheme 5: Plausible mechanistic route towards the synthesis of 
target compounds 6. 
Conclusion 
In summary, a new bifunctional nanosized ionic liquid catalyst, 
[4,4'-bipyridine]-1,1'-diium trinitromethanide (BPDTNM, 5), has 
been designed, synthesized, and fully characterized by FT-IR, 
1
H 
and 
13
C NMR, XRD, SEM, HRTEM, TG, DTG, DTA, and HPLC-mass 
spectrometry analyses. The constructed nanosized catalyst has 
been successfully applied for the synthesis of 1-
(benzoimidazolylamino)methyl-2-naphthol derivatives. The main 
merits of the present method are the robustness and high 
activity of the catalyst, the benign neat reaction conditions, an 
easy work-up and clean reaction profile, and the short reaction 
times with excellent yields. 
Experimental 
2.1. General information. 
All chemicals and solvents were of reagent grade and purchased 
from Sigma-Aldrich, Fluka, Merck, and Across Organic Chemical 
Companies. All reagents were used without any further 
purification. Solvents were dried, distilled and stored over 
molecular sieves. TLC was performed on UV-active aluminium-
backed silica gel plates F254 plates. Melting points were 
measured with a Thermo Scientific apparatus and are 
uncorrected. Fourier transform-infrared spectra (FT-IR) of the 
samples were recorded on a Perkin–Elmer FT-IR spectrometer 
17259 using KBr disks. 
1
H NMR (300 MHz and 400 MHz) spectra 
were obtained on a Bruker Avance 300 NMR and a Bruker 
Avance 400 NMR spectrometers, respectively, under proton 
coupled mode using deuterated DMSO as a solvent. 
13
C NMR 
(101 MHz) spectra were acquired on a Bruker Avance 400 NMR 
spectrometer in the proton decoupled mode at 20 °C in 
deuterated DMSO as solvent, unless otherwise stated. Chemical 
shifts are given in δ (parts per million) and the coupling 
constants (J) in hertz. 
19
F NMR (282 MHz) spectra were recorded 
on a Bruker Avance 300 NMR spectrometer, in proton coupled 
mode. Data for 
1
HNMR spectra is reported as follows: chemical 
shift (ppm), multiplicity (s, singlet; d, doublet; t, triplet; q, 
quartet; m, multiplet; and br, broad), coupling constant (Hz), and 
integration. Thermogravimetric analyses (TGA) were carried out 
on Perkin–Elmer TGA under nitrogen atmosphere at 25°C and 
using a heating rate of 10 °C min
-1
 up to 550 °C. High-resolution 
transmission electron microscopy (HRTEM) images were 
obtained using a JEOLJEM-2010 microscope operating with an 
accelerating voltage of 200 kv. Sample was prepared by drop 
casting the dispersed particles onto a 200-mesh copper grid 
coated with a holey carbon film. Scanning electron microscopy 
(SEM) studies were performed using a TESCAN/MIRA with a 
maximum acceleration voltage of the primary electrons between 
10 and 15 kV. X-ray diffraction (XRD) analysis was performed 
using a Bruker D8-Advance apparatus equipped with a 
monochromatized Cu Kα (λ= 0.154nm) X-ray source in the range 
2° < 2θ < 90°. Low resolution mass spectra (EI, 70 eV) were 
obtained using an Agilent 5973 Network spectrometer, with 
fragment ions m/z reported with relative intensities (%) in 
parentheses. Electrospray ionization low-resolution HPLC mass 
spectra were recorded on an Agilent 1100 series apparatus. 
General procedure for the synthesis of [4,4'-bipyridine]-1,1'-
diium trinitromethanide (BPDTNM) (5) as a nanosized ionic 
liquid catalyst (Scheme 2). 
To a round bottom flask containing 4,4'-bipyridine (5 mmol, 
0.780 g) dissolved in acetonitrile (15 mL), trinitromethane (10 
mmol, 1.51 g) was portion-wise added under vigorous stirring at 
room temperature. A light yellow powder was quickly formed 
and the stirring was continued for three hours. Then, the 
obtained powder was collected by filtration, washed with 
acetonitrile (3 × 5 mL) and air-dried. All spectral data confirmed 
the formation of [4,4'-bipyridine]-1,1'-diium trinitromethanide 
(BPDTNM, 5). 
General procedure for the synthesis of 1-
(benzoimidazolylamino)methyl-2-naphthol derivatives 6 using 
[4,4'-bipyridine]-1,1'-diium trinitromethanide (BPDTNM, 5) as a 
catalyst (Scheme 3). 
In a round bottom flask, to a mixture of the corresponding 
aromatic aldehyde (1 mmol), 2-naphtol (1 mmol, 0.144 g), and 2-
aminobenzimidazole (1 mmol, 0.133 g), [4,4'-bipyridine]-1,1'-
diium trinitromethanide (BPDTNM) 5 (1 mol%, 0.0046 g) was 
added. Then, the reaction mixture was stirred at 80 
o
C for the 
corresponding time, as indexed in Table 3, under neat 
conditions. The progress of the reaction was checked by TLC (n-
hexane/EtOAc). Once demonstrated full conversion, the reaction 
was quenched at room temperature. Purification of the 
obtained products by crystallization in hot EtOH afforded pure 
compounds 6, which were dried at 100 
o
C in an oven. 
Spectral data  
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 [4,4'-bipyridine]-1,1'-diium trinitromethanide (BPDTNM) (5): 
Isolated as a light yellow solid, Melting point: 94 – 96 °C; 
1
HNMR 
(300 MHz) δ 12.51 (br. s, 2H), 9.12 (m, 4H), 8.49 (m, 4H); 
13
CNMR 
(101 MHz) δ 160.9, 125.8, 122.6, 119.4; m/z (HPLC/+MS-ESI): 
157 [(4,4'-bipyridin)-1-ium].  
1-(((1H-benzo[d]imidazol-2-yl)amino)(4-
chlorophenyl)methyl)naphthalen-2-ol (6a): 
Isolated as white solid, (359 mg, 90%), Melting point: 195 – 197 
°C; FT-IR (KBr): υ (cm
-1
) = 3419, 3377, 3061, 1627, 1606, 1583, 
1466, 1266, 740; 
1
HNMR (400 MHz) δ 10.72 (br. s, 1H), 10.59 (br. 
s, 1H), 7.98 (br. s, 1H), 7.83 (d, J = 7.9, 1H), 7.79 (d, J = 8.9, 1H), 
7.45 (br. s, 2H), 7.34 – 7.22 (m, 6H), 7.17 (d, J = 8.5, 2H), 7.13 (d, 
J = 8.0, 1H), 6.69 (br. s, 2H); 
13
C NMR (101 MHz) δ 155.2, 153.1, 
142.5, 131.9, 130.6, 129.5, 128.7, 128.5, 127.9, 127.8, 126.6, 
122.6, 120.1, 119.4, 118.8, 114.8, 108.9, 51.4; MS (EI) m/z (%): 
254 (100), 144 (24), 133(9), 115 (12). 
 
1-(((1H-benzo[d]imidazol-2-yl)amino)(4-
methoxyphenyl)methyl)naphthalen-2-ol (6b): 
Isolated as white solid, (355 mg, 90%), Melting point: 171 – 173 
°C; FT-IR (KBr): υ (cm
-1
) = 3398, 3053, 2951, 1627, 1606, 1585, 
1508, 1466, 1437, 1266, 1175, 741; 
1
H NMR (300 MHz) δ 10.76 
(br. s, 2H), 8.01 (br. s, 1H), 7.82 (d, J = 8.0, 1H), 7.77 (d, J = 8.9, 
1H), 7.45 (br. s, 2H), 7.34 – 7.13 (m, 6H), 7.08 (d, J = 8.5, 1H), 
6.88 (br. s, 2H), 6.82 (d, J = 8.5, 2H), 3.68 (s, 3H); 
13
C NMR (101 
MHz) δ 158.2, 155.9, 153.6, 135.5, 132.5, 129.6, 129.1, 127.6, 
126.9, 123.6, 123.0, 120.5, 119.5, 119.2, 115.3, 113.9, 109.3, 
55.4, 52.0; MS (EI) m/z (%): 250 (100), 207 (12), 144 (21), 133 
(10), 115 (10). 
 
1-(((1H-benzo[d]imidazol-2-
yl)amino)(phenyl)methyl)naphthalen-2-ol (6c): 
Isolated as white solid, (325 mg, 89%), Melting point: 195 – 196 
°C; FT-IR (KBr): υ (cm
-1
) = 3405, 3380, 3058, 1634, 1608, 1587, 
1506, 1468, 1267, 1051, 747, 699, 522; 
1
H NMR (300 MHz) δ 
10.77 (br. s, 2H), 8.02 (br. s, 1H), 7.83 (d, J = 7.9, 1H), 7.79 (d, J = 
8.9, 1H), 7.57 – 7.36 (m, 2H), 7.35 – 7.20 (m, 6H), 7.20 – 7.11 (m, 
4H), 6.94 – 6.83 (m, 2H);
 13
C NMR (101 MHz) δ 155.9, 153.7, 
143.7, 132.6, 129.7, 129.1, 128.8, 128.5, 126.9, 126.6, 126.4, 
123.7, 123.0, 120.4, 119.9, 119.8, 119.5, 52.4; MS (EI) m/z (%): 
220 (26), 144 (100), 133 (10), 115 (46), 84 (38), 63 (42). 
 
1-(((1H-benzo[d]imidazol-2-yl)amino)(4-
bromophenyl)methyl)naphthalen-2-ol (6d): 
Isolated as white solid, (398 mg, 90%), Melting point: 199 – 201 
°C; FT-IR (KBr): υ (cm
-1
) = 3418, 3374, 3055, 1626, 1605, 1583, 
1516, 1465, 1357, 1266, 1070, 1010, 848, 742; 
1
H NMR (300 
MHz) δ 10.72 (br. s, 2H), 7.99 (br. s, 1H), 7.84 (d, J = 7.9, 1H), 
7.80 (d, J = 8.9, 1H), 7.46 (d, J = 8.5, 4H), 7.35 – 7.03 (m, 7H), 
6.96 – 6.83 (m, 2H); 
13
C NMR (101 MHz) δ 155.7, 153.7, 143.4, 
132.5, 131.3, 130.0, 129.2, 129.0, 128.7, 127.1, 123.5, 123.1, 
120.0, 119.9, 119.6, 119.3,112.6, 52.0; MS (EI) m/z (%): 300 (9), 
298 (9), 144 (100), 133 (8), 115 (46), 84 (12), 78 (30), 66 (14), 63 
(35).  
 
1-(((1H-benzo[d]imidazol-2-yl)amino)(2,6-
difluorophenyl)methyl)naphthalen-2-ol (6e): 
Isolated as white solid, (356 mg, 89%), Melting point: 152 – 154 
°C; FT-IR (KBr): υ (cm
-1
) = 3423, 3388, 3061, 2975, 1633, 1603, 
1579, 1511, 1465, 1308, 1264, 1046, 989, 746; 
1
H NMR (300 
MHz) δ 10.73 (br. s, 1H), 10.31 (br. s, 1H), 8.27 (d, J = 8.5, 1H), 
7.82 (d, J = 8.0, 1H), 7.77 (d, J = 8.9, 1H), 7.55 – 7.49 (m, 1H), 
7.41 – 7.32 (m, 1H), 7.33 – 7.08 (m, 6H), 6.98 – 6.83 (m, 4H); 
13
C 
NMR (101 MHz) δ, 161.4 (dd, J = 247.3, 8.0), 155.1, 154.0, 143.6, 
133.9, 132.3, 130.1, 129.0 – 128.6 (m), 127.1, 122.9, 122.7, 
120.5, 119.3 – 119.0 (m), 118.5, 115.5, 112.2 - 111.9 (m), 109.4, 
56.5; 
19
F NMR (282 MHz) δ -110.19; MS (EI) m/z (%): 257 (10), 
238 (39), 144 (100), 133 (15), 115 (46).  
 
1-(((1H-benzo[d]imidazol-2-yl)amino)(3,5-
difluorophenyl)methyl)naphthalen-2-ol (6f): 
Isolated as white solid, (369 mg, 92%), Melting point: 207 – 209 
°C; FT-IR (KBr): υ (cm
-1
) = 3409, 3089, 3055, 1626, 1605, 1577, 
1519, 1466, 1304, 1271, 1116, 983, 848, 819, 738, 536, 430; 
1
H 
NMR (300 MHz) δ 10.69 (br. s, 2H), 8.00 (br. s, 1H), 7.84 (t, J = 
8.5, 2H), 7.50 (br. t, J = 7.1, 2H), 7.35 – 7.14 (m, 5H), 7.05 (tt, J = 
9.0, 2.3, 1H), 6.91 (m, 4H); 
13
C NMR (101 MHz) δ 162.7 (dd, J = 
246.0, 13.0), 155.6, 153.7, 149.3 (t, J = 8.0), 132.4, 130.3, 129.2, 
129.0, 127.3, 123.2, 120.1, 119.9, 119.25, 119.18, 115.1, 109.7 – 
109.4 (m), 102.2 (t, J = 26.0), 52.1; 
19
F NMR (282 MHz) δ -108.10; 
MS (EI) m/z (%): 256 (22), 144 (100), 133 (9), 115 (47), 84 (25), 
78 (27), 66 (27), 63 (32).  
 
1-(((1H-benzo[d]imidazol-2-yl)amino)(4-
fluorophenyl)methyl)naphthalen-2-ol (6g): 
Isolated as white solid, (337 mg, 88%), Melting point: 195 – 196 
°C; FT-IR (KBr): υ (cm
-1
) = 3423, 3382, 3066, 1633, 1608, 1586, 
1504, 1467, 1435, 1267, 1053, 854, 736, 579, 504, 436; 
1
H NMR 
(300 MHz) δ 10.74 (br. s, 2H), 8.01 (br. s, 1H), 7.88 – 7.74 (m, 
2H), 7.58 – 7.37 (m, 2H), 7.36 – 7.21 (m, 4H), 7.20 – 7.04 (m, 5H), 
6.95 – 6.84 (m, 2H); 
13
C NMR (101 MHz) δ 161.2 (d, J = 242.0), 
155.8, 153.7, 151.0, 139.9, 132.5, 129.9, 129.1, 129.0, 128.3 (d, J 
= 8.0), 127.0, 123.4, 123.0, 121.7, 120.1, 119.9, 119.4, 115.2 (d, J 
= 21.0), 52.0; 
19
F NMR (282 MHz) δ -115.10; MS (EI) m/z (%): 238 
(38), 144 (100), 133 (9), 115 (66), 84 (13), 78 (22), 66 (14), 63 
(28).  
 
1-(((1H-benzo[d]imidazol-2-yl)amino)(p-
tolyl)methyl)naphthalen-2-ol (6h): 
Isolated as white solid, (330 mg, 87%), Melting point: 182 – 184 
°C; FT-IR (KBr): υ (cm
-1
) = 3395, 3374, 3058, 1627, 1605, 1582, 
1507, 1467, 1266, 1051, 814, 739, 482; 
1
H NMR (300 MHz) δ 
10.75 (br. s, 2H), 7.99 (br. s, 1H), 7.82 (d, J = 7.9, 1H), 7.77 (d, J = 
8.9, 1H), 7.58 – 7.34 (m, 2H), 7.33 – 7.00 (m, 9H), 6.95 – 6.82 (m, 
2H), 2.23 (s, 3H); 
13
C NMR (101 MHz) δ 155.9, 153.7, 140.6, 
135.6, 132.5, 129.8, 129.7, 129.4, 129.0, 126.8, 126.4, 123.6, 
122.9, 120.6, 119.9, 119.6, 119.5, 52.2, 21.0; MS (EI) m/z (%):144 
(100), 115 (52).  
 
1-(((1H-benzo[d]imidazol-2-yl)amino)(3-hydroxy-4-
methoxyphenyl)methyl)naphthalen-2-ol (6i): 
Isolated as white solid, (349 mg, 85%), Melting point: 166 – 168 
°C; FT-IR (KBr): υ (cm
-1
) = 3532, 3394, 3049, 1632, 1607, 1586, 
1505, 1468, 1264, 1123, 822, 739, 493; 
1
H NMR (300 MHz) δ 
10.74 (br. s, 2H), 8.81 (br. s, 1H), 7.99 (br. s, 1H), 7.82 (d, J = 7.9, 
1H), 7.77 (d, J = 8.9, 1H), 7.43 (br. s, 2H), 7.32 – 7.21 (m, 2H), 
7.20 – 7.12 (m, 2H), 7.02 (d, J = 8.5, 1H), 6.89 (br. s, 2H), 6.79 (d, 
J = 8.5, 1H), 6.77 – 6.61 (m, 2H), 3.69 (s, 3H); 
13
C NMR (101 MHz) 
δ 155.9, 153.7, 146.6, 146.5, 136.2, 132.6, 129.5, 129.0, 126.8, 
123.7, 122.9, 120.7, 120.0, 119.6, 119.4, 117.0, 114.2, 112.4, 
109.2,  56.1, 52.1; MS (EI) m/z (%):144 (100), 115 (66). 
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1-(((1H-benzo[d]imidazol-2-yl)amino)(3-ethoxy-4-
hydroxyphenyl)methyl)naphthalen-2-ol (6j): 
Isolated as pale yellow solid, (340 mg, 80%), Melting point: 182 – 
184 °C; FT-IR (KBr): υ (cm
-1
) = 3517, 3393, 3064, 2975, 1626, 
1606, 1584, 1509, 1468, 1434, 1406, 1352, 1267, 1121, 1043, 
827, 811, 740, 637, 506, 451; 
1
H NMR (300 MHz) δ 10.77 (br. s, 
1H), 8.76 (br. s, 1H), 8.11 – 7.95  (m, 1H), 7.90 – 7.64 (m, 3H), 
7.54 (br. s, 1H), 7.42 (br. s, 1H), 7.33 – 7.06 (m, 5H), 7.05 – 6.86 
(m, 3H), 6.78 – 6.54 (m, 2H), 3.94 – 3.70 (m, 2H), 1.21 (t, J = 7.8, 
7.0, 3H); 
13
C NMR (101 MHz) δ 155.9, 153.7, 146.7, 146.0, 145.3, 
134.6, 134.3, 132.6, 129.6, 129.0, 128.8, 126.2, 124.3, 122.9, 
122.5, 121.1, 119.5, 119.4, 115.8, 113.0, 64.4, 52.5, 15.1; MS (EI) 
m/z (%): 144 (100), 133 (7), 115 (53), 84 (13), 78 (19), 66 (14), 63 
(24).  
 
1-(((1H-benzo[d]imidazol-2-yl)amino)(3-
nitrophenyl)methyl)naphthalen-2-ol (6k): 
Isolated as yellow solid, (369 mg, 90%), Melting point: 197 – 198 
°C; FT-IR (KBr): υ (cm
-1
) = 3365, 3336, 3052, 1634, 1574, 1516, 
1465, 1350, 1269, 741, 701, 546; 
1
H NMR (300 MHz) δ 10.74 (br. 
s, 1H), 10.63 (br. s, 1H), 8.20 (s, 1H), 8.07 (dd, J = 7.8, 1.8, 2H), 
7.89 – 7.81 (m, 2H), 7.68 (d, J = 7.8, 1H), 7.60 – 7.46 (m, 3H), 
7.36 – 7.29 (m, 1H), 7.26 (d, J = 8.5, 2H), 7.23 – 7.17 (m, 2H), 
6.90 (d, J = 4.2, 2H); 
13
C NMR (101 MHz) δ 155.6, 153.7, 151.0, 
148.2, 146.6, 133.4, 132.4, 130.4, 130.1, 129.2, 128.9, 127.4, 
123.2, 121.8, 121.7, 120.9, 119.3, 119.2, 115.4, 109.4, 52.0; MS 
(EI) m/z (%): 276 (11), 265 (100), 230 (28), 219 (49), 202 (16), 
193 (14), 144 (54),115 (27). 
 
1-(((1H-benzo[d]imidazol-2-yl)amino)(2-
chlorophenyl)methyl)naphthalen-2-ol (6l): 
Isolated as white solid, (355 mg, 89%), Melting point: 144 – 146 
°C; FT-IR (KBr): υ (cm
-1
) = 3371, 3058, 1628, 1600, 1568, 1465, 
1270, 1043, 743; 
1
H NMR (300 MHz) δ 10.53 (br. s, 1H), 10.25 
(br. s, 1H), 8.13 (d, J = 8.5, 1H), 7.83 – 7.73 (m, 3H), 7.48 – 7.37 
(m, 2H), 7.36 – 7.22 (m, 4H), 7.22 – 7.12 (m, 4H), 6.94 – 6.80 (m, 
2H); 
13
C NMR (101 MHz) δ 155.1, 154.1, 140.9, 133.0, 132.7, 
130.1, 129.9, 129.8, 129.0, 128.8, 128.6, 126.7, 123.3, 122.8, 
119.9, 119.6, 119.3, 118.3, 109.1, 51.7; MS (EI) m/z (%):220 (11), 
144 (100), 133 (12), 115 (47), 84 (10), 78 (16), 63 (20).  
 
 
1-(((1H-benzo[d]imidazol-2-yl)amino)(3,4-
dimethoxyphenyl)methyl)naphthalen-2-ol (6m): 
Isolated as white solid, (352 mg, 83%), Melting point: 187 – 190 
°C; FT-IR (KBr): υ (cm
-1
) = 3393, 3052, 2935, 1632, 1606, 1586, 
1506, 1469, 1405, 1353, 1274, 1028, 1002, 822, 754, 742, 655, 
522 ; 
1
H NMR (300 MHz) δ 10.78 (br. s, 2H), 8.03 (br. s, 1H), 7.82 
(d, J = 7.9, 1H), 7.77 (d, J = 8.9, 1H), 7.54 (br. s, 1H), 7.49 – 7.36 
(m, 1H), 7.30 (d, J = 8.5, 1H), 7.24 (d, J = 8.8, 1H), 7.17 (d, J = 8.5, 
2H), 7.07 (d, J = 8.5, 1H), 7.01 (br. s, 1H), 6.89 (br. s, 2H), 6.83 (d, 
J = 8.4, 1H), 6.77 (dd, J = 8.5, 1.5, 1H), 3.68 (s, 3H), 3.60 (s, 3H); 
13
C NMR (101 MHz) δ 155.9, 153.7, 148.9, 147.9, 143.1, 136.0, 
132.6, 129.6, 129.0, 126.8, 123.8, 123.0, 120.6, 119.7, 118.9, 
115.1, 112.1, 111.0, 109.4, 55.9, 52.5; MS (EI) m/z (%): 292 (10), 
280 (100), 277 (11), 261 (32), 144 (11).  
 
1,1'-(1,4-phenylenebis(((1H-benzo[d]imidazol-2-
yl)amino)methylene))bis(naphthalen-2-ol) (6n): 
Isolated as yellow solid, (586 mg, 90 %), Melting point: 206 – 208 
°C; FT-IR (KBr): υ (cm
-1
) = 3383, 3058, 1628, 1603, 1572, 1515, 
1466, 1358, 1266, 819, 741; 
1
H NMR (300 MHz) δ 10.72 (br. s, 
4H), 7.99 (br. s, 2H), 7.86 – 7.59 (m, 5H), 7.59 – 7.33 (m, 4H), 
7.33 – 6.99 (m, 13H), 6.98 – 6.74 (m, 4H); 
13
C NMR (101 MHz) δ 
155.8, 153.6, 141.6, 132.5, 129.6, 129.0, 128.0, 126.5, 126.4, 
126.1, 123.1, 122.9, 120.5, 119.5, 119.1, 109.1, 52.2; MS (EI) m/z 
(%): 144 (100), 115 (55).  
 
 
1-(((1H-benzo[d]imidazol-2-yl)amino)(naphthalen-1-
yl)methyl)naphthalen-2-ol (6o): 
Isolated as yellow solid, (353 mg, 85%), Melting point: 149 – 151 
°C; FT-IR (KBr): υ (cm
-1
) = 3373, 3055, 1600, 1627, 1568, 1511, 
1464, 1269, 778, 742; 
1
H NMR (300 MHz) δ 10.64 (br. s, 2H), 
8.25 (d, J = 8.5, 1H), 8.07 (d, J = 8.5, 1H), 7.93 (d, J = 8.5, 1H), 
7.86 – 7.55 (m, 6H), 7.50 – 7.14 (m, 8H), 6.95 – 6.6.82 (m, 2H); 
13
C NMR (101 MHz) δ 155.4, 153.8, 138.3, 134.1, 133.1, 131.6, 
129.8, 129.1, 128.0, 126.8, 126.6, 126.4, 125.9, 125.6, 125.4, 
124.2, 123.4, 123.1, 122.9, 119.5, 119.1, 109.1, 51.4; MS (EI) m/z 
(%): 270 (10), 144 (100), 133 (13), 115 (47), 63 (10).  
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